SYS-CON MEDIA Authors: PR.com Newswire, RealWire News Distribution, Scott Kinka, Kevin Benedict, Gilad Parann-Nissany

News Feed Item

Kinapse is UK's Fastest Growing Life Science Services Company

LONDON, January 28, 2014 /PRNewswire/ --



The Sunday Times Fast Track listing has recognised Kinapse as one of the UK's fastest growing companies. Kinapse is also the fastest growing life sciences company to feature in the 2013 Fast Track 100.

Kinapse helps the world's largest life science companies to bring new medicines to patients and to support the monitoring of medicines' safety and effectiveness once approved.  The company has a unique model which deploys global expertise in strategic advisory services, change management and operational support services.

To support its exceptional growth, Kinapse is expanding its operations in US, Europe and India and this month opened new offices in New York and Bangalore. Kinapse is actively recruiting experienced life sciences professionals in all of these locations.  

Andy Black, CEO of Kinapse, said, "We have grown by an average of 70% in revenues for each of the last three years and will approach 500 people in the year ahead. Our unique service offering of 'Advise-Build-Operate' for life sciences clients is becoming an industry best practice which others are now seeking to emulate."

Chris Brinsmead is a Director of Kinapse and an Advisor to the Prime Minister, David Cameron, on the UK's Life Science Strategy.  Chris commented, "The UK has a proud history of creating and building life science companies and this remains an important platform for national economic growth and success.  Kinapse is exactly the kind of high growth company that the UK needs to strengthen this sector and enable the UK to continue to provide life science innovation to the world."

Nick Edwards, Chairman of Kinapse, said, "There are still many areas of unmet medical need and we are delighted to be working with nine of the top 10, and 17 of the top 20 global pharmaceutical companies, in bringing new medicines to patients that urgently need them."

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.